关注
Rajan Jog
Rajan Jog
U.S. Food and Drug Administration [2018-present] | University of Connecticut [2013-2018]
在 fda.hhs.gov 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pharmaceutical amorphous nanoparticles
R Jog, DJ Burgess
Journal of pharmaceutical sciences 106 (1), 39-65, 2017
1852017
Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres
JV Andhariya, R Jog, J Shen, S Choi, Y Wang, Y Zou, DJ Burgess
Journal of Controlled Release 308, 1-13, 2019
742019
In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release
JV Andhariya, R Jog, J Shen, S Choi, Y Wang, Y Zou, DJ Burgess
Journal of Controlled Release 314, 25-37, 2019
602019
Solid state drug-polymer miscibility studies using the model drug ABT-102
R Jog, R Gokhale, DJ Burgess
International journal of pharmaceutics 509 (1-2), 285-295, 2016
432016
In vitro release testing method development for ophthalmic ointments
Q Bao, J Shen, R Jog, C Zhang, B Newman, Y Wang, S Choi, DJ Burgess
International journal of pharmaceutics 526 (1-2), 145-156, 2017
402017
In Vitro and In Vivo Performance of Different Sized Spray‐Dried Crystalline Itraconazole
S Kumar, R Jog, J Shen, B Zolnik, N Sadrieh, DJ Burgess
Journal of pharmaceutical sciences 104 (9), 3018-3028, 2015
402015
Physicochemical attributes and dissolution testing of ophthalmic ointments
Q Bao, R Jog, J Shen, B Newman, Y Wang, S Choi, DJ Burgess
International journal of pharmaceutics 523 (1), 310-319, 2017
382017
Comprehensive quality by design approach for stable nanocrystalline drug products
R Jog, DJ Burgess
International journal of pharmaceutics 564, 426-460, 2019
362019
Formulation design and evaluation of amorphous ABT-102 nanoparticles
R Jog, S Kumar, J Shen, N Jugade, DCT Tan, R Gokhale, DJ Burgess
International journal of pharmaceutics 498 (1-2), 153-169, 2016
312016
Formulation and performance of danazol nano-crystalline suspensions and spray dried powders
S Kumar, R Jog, J Shen, B Zolnik, N Sadrieh, DJ Burgess
Pharmaceutical research 32, 1694-1703, 2015
262015
Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition
JR Pace, R Jog, DJ Burgess, MK Hadden
Journal of liposome research 30 (3), 305-311, 2020
222020
Formulation design space for stable, pH sensitive crystalline nifedipine nanoparticles
R Jog, K Unachukwu, DJ Burgess
International Journal of pharmaceutics 514 (1), 81-92, 2016
202016
Pectin microparticles for peptide delivery: Optimization of spray drying processing
T Li, B Wan, R Jog, A Costa, DJ Burgess
International Journal of Pharmaceutics 613, 121384, 2022
172022
Nanoamorphous drug products–Design and development
R Jog, DJ Burgess
International journal of pharmaceutics 553 (1-2), 238-260, 2018
142018
Excipients used in oral nanocarrier-based formulations
R Jog, DJ Burgess
Fundamentals of Nanoparticles, 279-342, 2018
52018
Effect of counterion on the solid state photodegradation behavior of prazosin salts
L Kumar, R Jog, S Singh, A Bansal
AAPS PharmSciTech 14, 757-763, 2013
42013
Evaluation of mucosal immune profile associated with Zileuton nanocrystal-formulated BCS-II drug upon oral administration in Sprague Dawley rats
S Khare, R Jog, A Bright, DJ Burgess, SK Chakder, K Gokulan
Nanotoxicology 17 (10), 583-603, 2023
22023
Characterization of Encapsulated Liposomal Irinotecan
JM Noble, L Chen, R Jog, D Kozak, J Zheng
Microscopy and Microanalysis 25 (S2), 1274-1275, 2019
22019
Use of Apparatus 4 in Dissolution Testing, Including Sparingly and Poorly Soluble Drugs
R Jog, GN Grove, DJ Burgess
Poorly Soluble Drugs, 279-324, 2017
22017
Evaluation of gender differences in the pharmacokinetics of oral zileuton nanocrystalline formulation using a rat model
CMR Muthumula, S Khare, R Jog, B Wickramaratne, A Lee, S Chakder, ...
International Journal of Pharmaceutics: X 7, 100254, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20